Gene Structure and Chromosomal Localization of the Human HSD11K Gene Encoding the Kidney (Type 2) Isozyme of 11β-Hydroxysteroid Dehydrogenase

Anil K. Agarwal, Fraser M. Rogerson, Tomoatsu Mune, Perrin C. White

Research output: Contribution to journalArticle

104 Citations (Scopus)

Abstract

11β-Hydroxysteroid dehydrogenase (11βHSD) converts glucocorticoids to inactive products and is thus thought to confer specificity for aldosterone on the type I mineralocorticoid receptor in the kidney. Recent studies indicate the presence of at least two isozymes of 11βHSD. In vitro, the NAD+-dependent kidney (type 2) isozyme catalyzes 11β-dehydrogenase but not reductase reactions, whereas the NADP+-dependent liver (type 1) isozyme catalyzes both reactions. We have now characterized the human gene encoding kidney 11βHSD (HSD11K). A bacteriophage P1 clone was isolated after screening a human genomic library by hybridization with sheep HSD11K cDNA. The gene consists of 5 exons spread over 6 kb. The nucleotide binding domain lies in the first and the second exon, and the catalytic domain in the fourth exon. The 5′ flanking sequences and first exon are GC-rich (80%), suggesting that the gene may he transcriptionally regulated by factors that recognize GC-rich sequences. Fluorescence in situ hybridization of metaphase chromosomes with a positive P1 clone localized the gene to chromosome 16q22. In contrast, the HSD11L (liver isozyme) gene is located on chromosome 1 and contains 6 exons; the coding sequences of these genes are only 21% identical. HSD11K is expressed at high levels in the placenta and kidney of midgestation human fetuses and at lower levels in lung and testes. Different transcriptional start sites are utilized in kidney and placenta. These data should be applicable to genetic analysis of the syndrome of apparent mineralocorticoid excess, which may represent a deficiency of 11βHSD.

Original languageEnglish (US)
Pages (from-to)195-199
Number of pages5
JournalGenomics
Volume29
Issue number1
DOIs
StatePublished - Sep 1 1995

Fingerprint

11-beta-Hydroxysteroid Dehydrogenases
Isoenzymes
Exons
Kidney
Genes
Placenta
Apparent Mineralocorticoid Excess Syndrome
Oxidoreductases
Clone Cells
Chromosomes
Bacteriophage P1
GC Rich Sequence
Nucleic Acid Hybridization
Mineralocorticoid Receptors
Genomic Library
5' Flanking Region
Chromosomes, Human, Pair 1
Liver
Metaphase
Aldosterone

ASJC Scopus subject areas

  • Genetics

Cite this

Gene Structure and Chromosomal Localization of the Human HSD11K Gene Encoding the Kidney (Type 2) Isozyme of 11β-Hydroxysteroid Dehydrogenase. / Agarwal, Anil K.; Rogerson, Fraser M.; Mune, Tomoatsu; White, Perrin C.

In: Genomics, Vol. 29, No. 1, 01.09.1995, p. 195-199.

Research output: Contribution to journalArticle

@article{a0129729bf5d42f29e2cc878dc940a9e,
title = "Gene Structure and Chromosomal Localization of the Human HSD11K Gene Encoding the Kidney (Type 2) Isozyme of 11β-Hydroxysteroid Dehydrogenase",
abstract = "11β-Hydroxysteroid dehydrogenase (11βHSD) converts glucocorticoids to inactive products and is thus thought to confer specificity for aldosterone on the type I mineralocorticoid receptor in the kidney. Recent studies indicate the presence of at least two isozymes of 11βHSD. In vitro, the NAD+-dependent kidney (type 2) isozyme catalyzes 11β-dehydrogenase but not reductase reactions, whereas the NADP+-dependent liver (type 1) isozyme catalyzes both reactions. We have now characterized the human gene encoding kidney 11βHSD (HSD11K). A bacteriophage P1 clone was isolated after screening a human genomic library by hybridization with sheep HSD11K cDNA. The gene consists of 5 exons spread over 6 kb. The nucleotide binding domain lies in the first and the second exon, and the catalytic domain in the fourth exon. The 5′ flanking sequences and first exon are GC-rich (80{\%}), suggesting that the gene may he transcriptionally regulated by factors that recognize GC-rich sequences. Fluorescence in situ hybridization of metaphase chromosomes with a positive P1 clone localized the gene to chromosome 16q22. In contrast, the HSD11L (liver isozyme) gene is located on chromosome 1 and contains 6 exons; the coding sequences of these genes are only 21{\%} identical. HSD11K is expressed at high levels in the placenta and kidney of midgestation human fetuses and at lower levels in lung and testes. Different transcriptional start sites are utilized in kidney and placenta. These data should be applicable to genetic analysis of the syndrome of apparent mineralocorticoid excess, which may represent a deficiency of 11βHSD.",
author = "Agarwal, {Anil K.} and Rogerson, {Fraser M.} and Tomoatsu Mune and White, {Perrin C.}",
year = "1995",
month = "9",
day = "1",
doi = "10.1006/geno.1995.1231",
language = "English (US)",
volume = "29",
pages = "195--199",
journal = "Genomics",
issn = "0888-7543",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Gene Structure and Chromosomal Localization of the Human HSD11K Gene Encoding the Kidney (Type 2) Isozyme of 11β-Hydroxysteroid Dehydrogenase

AU - Agarwal, Anil K.

AU - Rogerson, Fraser M.

AU - Mune, Tomoatsu

AU - White, Perrin C.

PY - 1995/9/1

Y1 - 1995/9/1

N2 - 11β-Hydroxysteroid dehydrogenase (11βHSD) converts glucocorticoids to inactive products and is thus thought to confer specificity for aldosterone on the type I mineralocorticoid receptor in the kidney. Recent studies indicate the presence of at least two isozymes of 11βHSD. In vitro, the NAD+-dependent kidney (type 2) isozyme catalyzes 11β-dehydrogenase but not reductase reactions, whereas the NADP+-dependent liver (type 1) isozyme catalyzes both reactions. We have now characterized the human gene encoding kidney 11βHSD (HSD11K). A bacteriophage P1 clone was isolated after screening a human genomic library by hybridization with sheep HSD11K cDNA. The gene consists of 5 exons spread over 6 kb. The nucleotide binding domain lies in the first and the second exon, and the catalytic domain in the fourth exon. The 5′ flanking sequences and first exon are GC-rich (80%), suggesting that the gene may he transcriptionally regulated by factors that recognize GC-rich sequences. Fluorescence in situ hybridization of metaphase chromosomes with a positive P1 clone localized the gene to chromosome 16q22. In contrast, the HSD11L (liver isozyme) gene is located on chromosome 1 and contains 6 exons; the coding sequences of these genes are only 21% identical. HSD11K is expressed at high levels in the placenta and kidney of midgestation human fetuses and at lower levels in lung and testes. Different transcriptional start sites are utilized in kidney and placenta. These data should be applicable to genetic analysis of the syndrome of apparent mineralocorticoid excess, which may represent a deficiency of 11βHSD.

AB - 11β-Hydroxysteroid dehydrogenase (11βHSD) converts glucocorticoids to inactive products and is thus thought to confer specificity for aldosterone on the type I mineralocorticoid receptor in the kidney. Recent studies indicate the presence of at least two isozymes of 11βHSD. In vitro, the NAD+-dependent kidney (type 2) isozyme catalyzes 11β-dehydrogenase but not reductase reactions, whereas the NADP+-dependent liver (type 1) isozyme catalyzes both reactions. We have now characterized the human gene encoding kidney 11βHSD (HSD11K). A bacteriophage P1 clone was isolated after screening a human genomic library by hybridization with sheep HSD11K cDNA. The gene consists of 5 exons spread over 6 kb. The nucleotide binding domain lies in the first and the second exon, and the catalytic domain in the fourth exon. The 5′ flanking sequences and first exon are GC-rich (80%), suggesting that the gene may he transcriptionally regulated by factors that recognize GC-rich sequences. Fluorescence in situ hybridization of metaphase chromosomes with a positive P1 clone localized the gene to chromosome 16q22. In contrast, the HSD11L (liver isozyme) gene is located on chromosome 1 and contains 6 exons; the coding sequences of these genes are only 21% identical. HSD11K is expressed at high levels in the placenta and kidney of midgestation human fetuses and at lower levels in lung and testes. Different transcriptional start sites are utilized in kidney and placenta. These data should be applicable to genetic analysis of the syndrome of apparent mineralocorticoid excess, which may represent a deficiency of 11βHSD.

UR - http://www.scopus.com/inward/record.url?scp=0029095113&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029095113&partnerID=8YFLogxK

U2 - 10.1006/geno.1995.1231

DO - 10.1006/geno.1995.1231

M3 - Article

C2 - 8530071

AN - SCOPUS:0029095113

VL - 29

SP - 195

EP - 199

JO - Genomics

JF - Genomics

SN - 0888-7543

IS - 1

ER -